Claim Missing Document
Check
Articles

Found 2 Documents
Search

Characteristics Of Patients With Lymphoma Diagnosis At Gunung Jati Cirebon Hospital In 2022-2024 Ziya Ulhaq; Asih Ambarsari; Nurbaiti
Indonesian Health Issue Vol. 5 No. 1 (2026): FEBRUARY
Publisher : Indonesian Journal Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47134/inhis.v5i1.140

Abstract

ABSTRACT Background: Lymphoma is a malignancy of the lymphoid system that can involve lymph nodes and extranodal sites and remains a public health problem with an increasing incidence. Data on the characteristics of lymphoma patients in regional hospitals are still limited. Objective: To describe the characteristics of patients diagnosed with lymphoma at Gunung Jati Regional Hospital, Cirebon. Methods: This was a retrospective descriptive study using medical record data of lymphoma patients treated at Gunung Jati Regional Hospital during the period 2022–2024. Total sampling was applied. The variables analyzed included age, sex, clinical manifestations, tumor location, histopathological and immunohistochemical findings, treatment, and recurrence. Results: Of the 90 patients, most were male and belonged to the older age group. The most common clinical manifestation was a lump or mass, with predominant extranodal involvement. Most patients were diagnosed with Non-Hodgkin Lymphoma, with Diffuse Large B-Cell Lymphoma as the most frequent immunohistochemical subtype. Chemotherapy was the most commonly administered treatment, and no recurrence data were found during the observation period. Conclusion: Lymphoma patients at Gunung Jati Regional Hospital, Cirebon, during 2022–2024 were predominantly older males with extranodal involvement and Non-Hodgkin Lymphoma, particularly Diffuse Large B-Cell Lymphoma. These findings are important as a basis for clinical mapping and planning of lymphoma services in regional hospitals.
Effects of Dietary Fiber Interventions on Gut Health and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review of Human Intervention Studies Qyana Al Farisi; Ade Erni Tanjung; Ziya Ulhaq
Eduvest - Journal of Universal Studies Vol. 6 No. 9 (2026): Eduvest - Journal of Universal Studies
Publisher : Green Publisher Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59188/eduvest.v6i9.53339

Abstract

Type 2 diabetes mellitus (T2DM) is a rapidly increasing global health burden, with dietary fiber proposed as a modifiable nutritional strategy to improve glycemic control and gut health. However, clinical evidence regarding different fiber types and underlying mechanisms remains heterogeneous. This systematic review aimed to evaluate the effects of dietary fiber interventions on gut microbiota composition and glycemic outcomes in adults with T2DM. A systematic literature search was conducted in PubMed, ScienceDirect, the Cochrane Library, and Europe PMC in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Human intervention studies, including randomized controlled trials, crossover trials, and controlled clinical trials involving adults with T2DM receiving dietary fiber supplementation or high-fiber dietary interventions, were eligible for inclusion. Risk of bias was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist.Twenty-six studies involving 1,601 participants were included. Dietary fiber interventions consistently improved glycemic outcomes, with the most consistent effects observed in reductions in fasting glucose and glycated hemoglobin (HbA1c), particularly with psyllium and inulin supplementation. Improvements in postprandial glucose responses were demonstrated across multiple fiber types in acute and short-term interventions. Dietary fiber supplementation may improve glycemic control in individuals with T2DM, with preliminary evidence suggesting that modulation of gut microbiota may contribute to these effects. Standardized, long-term clinical trials integrating metabolic and microbiota-related outcomes are required to further clarify these mechanisms.